CAJ | 학술논문

目的：引用不同参数比较输尿管结石实施临床路径模式与传统治疗模式的不同及原因分析。方法164例输尿管结石分四组：A组为临床路径治疗单纯结石，B组为临床路径治疗结石合并其他疾病，C组为传统模式治疗单纯结石，D组为传统模式治疗结石合并其他疾病。全部病例均在各类麻醉下使用输尿管硬镜弹道碎石术。A组56例，B组30例，C组46例， D组32例。采用统计学方法从术前平均住院日、平均住院日、住院总费用、药占比、抗生素比、患者满意度调查等各参数进行比较。结果 A组各指标均优于B、C、D三组，差异有统计学意义（P＜0.05）；B组各指标与C组持平（P＞0.05）；B、C两组各指标均优于D组，差异有统计学意义（P＜0.05）。结论无合并其他疾病的单纯输尿管中下段结石实施临床路径模式治疗效果较好，总体疗效满意，临床路径模式还需进一步完善。
목적：인용불동삼수비교수뇨관결석실시림상로경모식여전통치료모식적불동급원인분석。방법164례수뇨관결석분사조：A조위림상로경치료단순결석，B조위림상로경치료결석합병기타질병，C조위전통모식치료단순결석，D조위전통모식치료결석합병기타질병。전부병례균재각류마취하사용수뇨관경경탄도쇄석술。A조56례，B조30례，C조46례， D조32례。채용통계학방법종술전평균주원일、평균주원일、주원총비용、약점비、항생소비、환자만의도조사등각삼수진행비교。결과 A조각지표균우우B、C、D삼조，차이유통계학의의（P＜0.05）；B조각지표여C조지평（P＞0.05）；B、C량조각지표균우우D조，차이유통계학의의（P＜0.05）。결론무합병기타질병적단순수뇨관중하단결석실시림상로경모식치료효과교호，총체료효만의，림상로경모식환수진일보완선。
Objective To compare the differences of ureteral calculus between Implementation of clinical pathway and Traditional treatment mode by different parameter. Methods 164 cases of ureteral stones were divided into four groups:group A is the clinical path treatment of simple calculi, group B is clinical path treatment of calculi with other diseases, group C is the traditional mode of treatment of simple calculi, group D is the traditional mode of treatment of calculi complicated with other diseases. All patients were using ureteroscopic lithotripsy in all kinds of anesthesia. 56 cases in group A, 30 cases in group B, 46 cases in group C, group D of 32 cases. The preoperative waiting to bed days, average hospitalization days, total cost of hospitalization, drug for each parameter ratio, antibiotics, patients satisfaction survey are compared. Results In group A, the indicators are better than group B, C, D, the difference was statistically significant (P<0.05);indexes of group B and group C were flat (P>0.05);indicators of B, C groups are better than the group D, the difference was statistically significant (P<0.05). Conclusion The implementation effect of clinical pathway model treatment Without other diseases combined with simple ureteral calculus is good, the overall effect is satisfactory. clinical pathway model still need further perfect.